Low serum cholesteryl ester-docosahexaenoic acid levels in Alzheimer's disease: a case–control study
- 1 April 2003
- journal article
- Published by Cambridge University Press (CUP) in British Journal of Nutrition
- Vol. 89 (4) , 483-489
- https://doi.org/10.1079/bjn2002804
Abstract
Low serum cholesteryl ester-docosahexaenoic acid levels in Alzheimer's disease: a case–control study - Volume 89 Issue 4 - A. M. Tully, H. M. Roche, R. Doyle, C. Fallon, I. Bruce, B. Lawlor, D. Coakley, M. J. GibneyKeywords
This publication has 41 references indexed in Scilit:
- Omega 3 Fatty Acids in Bipolar DisorderArchives of General Psychiatry, 1999
- Low serum docosahexaenoic acid is a significant risk factor for alzheimer's dementiaLipids, 1999
- Fish Consumption and Risk of Sudden Cardiac DeathJAMA, 1998
- Randomized, Double-Blind, Placebo-Controlled Trial of Fish Oil and Mustard Oil in Patients with Suspected Acute Myocardial Infarction: The Indian Experiment of Infarct Survival—4Cardiovascular Drugs and Therapy, 1997
- Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam StudyThe Lancet, 1997
- Polyunsaturated Fatty Acids, Antioxidants, and Cognitive Function in Very Old MenAmerican Journal of Epidemiology, 1997
- A case‐control study of Alzheimer's disease in AustraliaNeurology, 1990
- Fatty acid composition of serum cholesteryl esters and erythrocyte membranes as indicators of linoleic acid intake in manThe American Journal of Clinical Nutrition, 1989
- n-3 Fatty Acids in the Brain and Retina: Evidence for Their EssentialityNutrition Reviews, 1986
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984